TRG Latin America Acquisitions(TRGSU)
Search documents
TRG Latin America Acquisitions Corp. Announces Closing of Partial Exercise of IPO Over-Allotment Option
Globenewswire· 2026-03-27 20:30
Core Viewpoint - TRG Latin America Acquisitions Corp. has successfully completed a partial exercise of the underwriter's over-allotment option, resulting in additional gross proceeds of $6,320,000 from the sale of 632,000 units at $10.00 per unit, increasing total gross proceeds from the initial public offering to $206,320,000 [1][2]. Group 1 - The total number of units sold in the public offering has increased to 20,632,000 units following the partial exercise of the over-allotment option [2]. - The offering consists of units that include one Class A ordinary share and one right, which entitles the holder to receive one-tenth of one Class A ordinary share upon the completion of an initial business combination [3]. - The Class A ordinary shares and rights are expected to be listed on Nasdaq under the symbols "TRGS" and "TRGSR," respectively, once separate trading begins [3]. Group 2 - Santander acted as the sole book-running manager for the offering [3]. - A registration statement for the securities was filed with the U.S. Securities and Exchange Commission and became effective on February 25, 2026 [5]. - The offering was conducted through a prospectus, which can be obtained from Santander US Capital Markets LLC [4].
TRG Latin America Acquisitions Corp. Completes $200 Million Initial Public Offering
Globenewswire· 2026-02-27 21:00
Core Viewpoint - TRG Latin America Acquisitions Corp. successfully closed its initial public offering (IPO) of 20,000,000 units at a price of $10.00 per unit, generating gross proceeds of $200,000,000, with trading commencing on Nasdaq under the ticker symbol "TRGSU" [1] Group 1: IPO Details - The IPO consists of 20,000,000 units priced at $10.00 each, resulting in gross proceeds of $200,000,000 [1] - Each unit includes one Class A ordinary share and one right to receive one-tenth of one Class A ordinary share upon a business combination [1] - The Class A ordinary shares and rights are expected to begin separate trading within 52 days, listed under the symbols "TRGS" and "TRGSR" respectively [1] Group 2: Underwriting and Options - Santander acted as the sole book-running manager for the IPO [2] - The underwriter has a 45-day option to purchase an additional 3,000,000 units at the initial offering price to cover over-allotments [2] Group 3: Company Overview - TRG Latin America Acquisitions Corp. is a blank check company formed to pursue mergers, amalgamations, share exchanges, asset acquisitions, or similar business combinations [4] - The company aims to leverage the expertise of its management team, particularly focusing on opportunities in Argentina [4] - Key management includes CEO and Chairman Nicolas S. Rohatyn and CFO Miguel A. Gutierrez, both co-founders of The Rohatyn Group [4]
美股迎3只新股上市 今晚还有1只
Sou Hu Cai Jing· 2026-02-27 07:52
Group 1 - APEX Tech Acquisition, TRG Latin America Acquisitions, and Fortress Value Acquisition V collectively raised $550 million in the US stock market on February 26, 2026 [1][2] - APEX Tech Acquisition, led by Shaoren Liu from China, targets US companies with no industry restrictions, focusing on cash flow, technological leadership, and management teams [2] - TRG Latin America Acquisitions, initiated by Nicolas Rohatyn, focuses on growth sectors in Latin America, particularly Argentina, targeting energy, mining, agriculture, and technology [2] - Fortress Value Acquisition V, led by Andrew McKnight, has no geographic or industry restrictions and aims to find companies that can provide attractive risk-adjusted returns [2] Group 2 - Generate Biomedicines plans to raise $400 million by issuing 25 million shares at $16 each, with the funds allocated for clinical trials, platform innovation, candidate drug development, and general corporate purposes [4] - Generate Biomedicines is a tech-driven biopharmaceutical company utilizing an AI platform to design, test, and advance new drug candidates to address biological challenges that traditional technologies struggle with [4] - Projected revenues for Generate Biomedicines are $20.46 million and $31.89 million for 2024 and 2025, respectively, with corresponding net losses of $181 million and $223 million [4]
TRG Latin America Acquisitions Corp. Announces Pricing of $200 Million Initial Public Offering
Globenewswire· 2026-02-26 01:27
Company Overview - TRG Latin America Acquisitions Corp. is a blank check company incorporated in the Cayman Islands, formed to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses [4] - The company intends to leverage the expertise of its management team, particularly focusing on identifying a target business that can benefit from the experience of its CEO and Chairman Nicolas S. Rohatyn and CFO Miguel A. Gutierrez [5] Initial Public Offering (IPO) Details - The company has priced its initial public offering at $10.00 per unit, with a total of 20,000,000 units being offered [1] - The units will be listed on the Nasdaq Stock Exchange under the ticker symbol "TRGSU" starting February 26, 2026, and will consist of one Class A ordinary share and one right entitling the holder to receive one-tenth of one Class A ordinary share upon the completion of a business combination [1] - The offering includes a 45-day option for the underwriter, Santander, to purchase up to an additional 3,000,000 units at the IPO price to cover over-allotments [2] - The offering is expected to close on February 27, 2026, subject to customary closing conditions [3] Management and Board Members - The management team includes Nicolas S. Rohatyn as CEO and Chairman, and Miguel A. Gutierrez as CFO, both of whom are co-founders and partners at The Rohatyn Group [5] - The board of directors will include Miguel Kiguel, Daniel Gerold, and Thomas Wolf [6]
TRG Latin America Acquisitions(TRGSU) - Prospectus(update)
2026-02-20 15:33
As Filed with the U.S. Securities and Exchange Commission on February 20, 2026 Registration No. 333-293354 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No. 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ______________________________________ TRG LATIN AMERICA ACQUISITIONS CORP. (Exact name of registrant as specified in its charter) ______________________________________ | Cayman Islands | 6770 | 98-1896935 | | --- | --- | --- | | (State or other ju ...
TRG Latin America Acquisitions(TRGSU) - Prospectus
2026-02-10 21:55
As Filed with the U.S. Securities and Exchange Commission on February 10, 2026 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ______________________________________ TRG LATIN AMERICA ACQUISITIONS CORP. (Exact name of registrant as specified in its charter) ______________________________________ | Cayman Islands | 6770 | 98-1896935 | | --- | --- | --- | | (State or other jurisdiction of | (Primary ...